The mechanosensitive APJ internalization via clathrin-mediated endocytosis: A new molecular mechanism of cardiac hypertrophy

Medical Hypotheses

Volumn 90, Issue , 2016, Pages 6-10

  He, Lu ^a   Chen, Linxi ^a   Li, Lanfang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); APELIN; APELIN 13; APELIN RECEPTOR; CLATHRIN; HYDROGEN PEROXIDE; OUABAIN; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; APLN PROTEIN, HUMAN; APLNR PROTEIN, HUMAN; ELA PEPTIDE, HUMAN; G PROTEIN COUPLED RECEPTOR; LIGAND; PEPTIDE HORMONE; SIGNAL PEPTIDE;

ARTICLE; AUTOPHAGY; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; ENDOCYTOSIS; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; INTERNALIZATION; LIGAND BINDING; MOLECULARLY TARGETED THERAPY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; AGONISTS; BIOLOGICAL MODEL; CARDIOMEGALY; CLATHRIN-COATED VESICLE; MECHANOTRANSDUCTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

CARDIOMEGALY; CLATHRIN; CLATHRIN-COATED VESICLES; ENDOCYTOSIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MECHANOTRANSDUCTION, CELLULAR; MODELS, CARDIOVASCULAR; PEPTIDE HORMONES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84959256947     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2016.02.017     Document Type: Article

References (54)

1. Komuro I. Molecular mechanism of mechanical stress-induced cardiac hypertrophy. Jpn Heart J 2000, 41:117-129.
2. Dzau V.J. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. Curr Opin Nephrol Hypertens 1993, 2:27-32.
3. O'Dowd B.F., Heiber M., Chan A., et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993, 136:355-360.
4. Tatemoto K., Hosoya M., Habata Y., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998, 251:471-476.
5. Japp A.G., Newby D.E. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem Pharmacol 2008, 75:1882-1892.
6. He L., Xu J., Chen L., Li L. Apelin/APJ signaling in hypoxia-related diseases. Clin Chim Acta 2015, 451:191-198.
7. Cao J., Li H., Chen L. Targeting drugs to APJ receptor: the prospect of treatment of hypertension and other cardiovascular diseases. Curr Drug Targets 2015, 16:148-155.
8. Wu D., He L., Chen L. Apelin/APJ system: a promising therapy target for hypertension. Mol Biol Rep 2014, 41:6691-6703.
9. Lv D., Li H., Chen L. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis. Acta Biochim Biophys Sin (Shanghai) 2013, 45:527-533.
10. Yang L., Su T., Lv D., et al. ERK1/2 mediates lung adenocarcinoma cell proliferation and autophagy induced by apelin-13. Acta Biochim Biophys Sin (Shanghai) 2014, 46:100-111.
11. Pauli A., Norris M.L., Valen E., et al. Toddler: an embryonic signal that promotes cell movement via Apelin receptors. Science (New York, NY) 2014, 343:1248636.
12. Wang Z., Yu D., Wang M., et al. Elabela-apelin receptor signaling pathway is functional in mammalian systems. Sci Rep 2015, 5:8170.
13. Ashley E.A., Powers J., Chen M., et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005, 65:73-82.
14. Scimia M.C., Hurtado C., Ray S., et al. APJ acts as a dual receptor in cardiac hypertrophy. Nature 2012, 488:394-398.
15. Xie F., Liu W., Feng F., et al. A static pressure sensitive receptor APJ promote H9c2 cardiomyocyte hypertrophy via PI3K-autophagy pathway. Acta Biochim Biophys Sin (Shanghai) 2014, 46:699-708.
16. Sklan A. Additional role for APJ in cardiac hypertrophy. Future Med. Chem. 2012, 4:1660.
17. Stahl P., Schwartz A.L. Receptor-mediated endocytosis. J Clin Investig 1986, 77:657-662.
18. Takano M., Kawami M., Aoki A., Yumoto R. Receptor-mediated endocytosis of macromolecules and strategy to enhance their transport in alveolar epithelial cells. Expert Opin Drug Deliv 2015, 12:813-825.
19. Rosenfeld M.E., Bowen-Pope D.F., Ross R. Platelet-derived growth factor: morphologic and biochemical studies of binding, internalization, and degradation. J Cell Physiol 1984, 121:263-274.
20. Wolfe B.L., Trejo J. Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis. Traffic (Copenhagen, Denmark) 2007, 8:462-470.
21. Zeng H., He X., Hou X., Li L., Chen J.X. Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3. Am J Physiol Heart Circ Physiol 2014, 306:H585-597.
22. Ye L., Ding F., Zhang L., et al. Serum apelin is associated with left ventricular hypertrophy in untreated hypertension patients. J Transl Med 2015, 13:290.
23. Li L., Zeng H., Hou X., He X., Chen J.X. Myocardial injection of apelin-overexpressing bone marrow cells improves cardiac repair via upregulation of Sirt3 after myocardial infarction. PLoS ONE 2013, 8:e71041.
24. Ceylan-Isik A.F., Kandadi M.R., Xu X., et al. Apelin administration ameliorates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J Mol Cell Cardiol 2013, 63:4-13.
25. Li L., Zeng H., Chen J.X. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circ Physiol 2012, 303:H605-618.
26. Pchejetski D., Foussal C., Alfarano C., et al. Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1. Eur Heart J 2012, 33:2360-2369.
27. Foussal C., Lairez O., Calise D., et al. Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Lett 2010, 584:2363-2370.
28. Falcao-Pires I., Goncalves N., Henriques-Coelho T., Moreira-Goncalves D., Roncon-Albuquerque R., Leite-Moreira A.F. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009, 296:H2007-2014.
29. Xie F., Liu W., Feng F., et al. A static pressure sensitive receptor APJ promote H9c2 cardiomyocyte hypertrophy via PI3K-autophagy pathway. Acta Biochim Biophys Sin 2014, 46:699-708.
30. Soeiro Mde N., Mota R.A., Batista Dda G., Meirelles Mde N. Endocytic pathway in mouse cardiac cells. Cell Struct Funct 2002, 27:469-478.
31. Wu G., Yussman M.G., Barrett T.J., et al. Increased myocardial Rab GTPase expression: a consequence and cause of cardiomyopathy. Circ Res 2001, 89:1130-1137.
32. Balasubramanian S., Kuppuswamy D. RGD-containing peptides activate S6K1 through beta3 integrin in adult cardiac muscle cells. J Biol Chem 2003, 278:42214-42224.
33. Morisco C., Marrone C., Galeotti J., et al. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes. Cardiovasc Res 2008, 78:36-44.
34. Perrino C., Rockman H.A., Chiariello M. Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure. Vascul Pharmacol 2006, 45:77-85.
35. Yang H., Liu Y., Lu X.L., Li X.H., Zhang H.G. Transmembrane transport of the Galphaq protein carboxyl terminus imitation polypeptide GCIP-27. Eur J Pharm Sci 2013, 49:791-799.
36. Gilsbach R., Schneider J., Lother A., Schickinger S., Leemhuis J., Hein L. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload. Cardiovasc Res 2010, 86:432-442.
37. Liu J. Ouabain-induced endocytosis and signal transduction of the Na/K-ATPase. Front Biosci 2005, 10:2056-2063.
38. Liu L., Li J., Liu J., et al. Involvement of Na+/K+-ATPase in hydrogen peroxide-induced hypertrophy in cardiac myocytes. Free Radical Biol Med 2006, 41:1548-1556.
39. Iturrioz X., Alvear-Perez R., De Mota N., et al. Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist. FASEB J 2010, 24:1506-1517.
40. Margathe J.F., Iturrioz X., Alvear-Perez R., et al. Structure-activity relationship studies toward the discovery of selective apelin receptor agonists. J Med Chem 2014, 57:2908-2919.
41. Brame A.L., Maguire J.J., Yang P., et al. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist. Hypertension 2015, 65:834-840.
42. Friis K.P., Iturrioz X., Thomsen J., et al. Directed molecular evolution of an engineered gammaretroviral envelope protein with dual receptor use shows stable maintenance of both receptor specificities. J Virol 2015.
43. Reaux A., De Mota N., Skultetyova I., et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 2001, 77:1085-1096.
44. El Messari S., Iturrioz X., Fassot C., De Mota N., Roesch D., Llorens-Cortes C. Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. J Neurochem 2004, 90:1290-1301.
45. Iturrioz X., El Messari S., De Mota N., et al. Functional dissociation between apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. Arch Mal Coeur Vaiss 2007, 100:704-708.
46. Llorens-Cortes C., Beaudet A. Apelin, a neuropeptide that counteracts vasopressin secretion. Med Sci 2005, 21:741-746.
47. Iturrioz X., Gerbier R., Leroux V., Alvear-Perez R., Maigret B., Llorens-Cortes C. By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization. J Biol Chem 2010, 285:32627-32637.
48. Ceraudo E., Galanth C., Carpentier E., et al. Biased signaling favoring gi over beta-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine. J Biol Chem 2014, 289:24599-24610.
49. Chen X., Bai B., Tian Y., Du H., Chen J. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling. J Biol Chem 2014, 289:31173-31187.
50. Evans N.A., Groarke D.A., Warrack J., et al. Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors. J Neurochem 2001, 77:476-485.
51. Zhou N., Fan X., Mukhtar M., et al. Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ. Virology 2003, 307:22-36.
52. Lee D.K., Ferguson S.S., George S.R., O'Dowd B.F. The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin. Biochem Biophys Res Commun 2010, 395:185-189.
53. Endoh M. Novel signalling cascade for cardiac hypertrophy activation by uncoupling and internalization of beta1-adrenoceptors. Cardiovasc Res 2008, 78:5-7.
54. Vatner S.F., Vatner D.E., Homcy C.J. Beta-adrenergic receptor signaling: an acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models. Circ Res 2000, 86:502-506.